Latest Breaking News On - Ableson tyrosine - Page 1 : comparemela.com

Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro

Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesMiltonh wernerMilton wernerAlex loboDivision of hematologic malignanciesWhile the companyCompany contactInhibikase therapeutics incStern investor relations incExchange commissionDrug administrationInhibikase or companyTherapeutics announces full outcomesAbelson tyrosine kinasesChief executive officerHematologic malignancies

Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro

Inhibikase Therapeutics Announces Full Outcomes of its Pre-NDA Meeting with the FDA for IkT-001Pro
businessinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from businessinsider.com Daily Mail and Mail on Sunday newspapers.

United statesAlex loboMilton wernerMiltonh wernerExchange commissionStern investor relations incDrug administrationCompany contactWhile the companyInhibikase therapeutics incDivision of hematologic malignanciesInhibikase or companyAbelson tyrosine kinasesChief executive officerHematologic malignanciesReview team

Inhibikase Therapeutics Announces Preliminary Outcomes of its Pre-NDA Meeting with the FDA on the Pathway for Approval for IkT-001Pro in Blood and Gastrointestinal Cancers

- The Company continues to progress the 201 Trial evaluating risvodetinib in untreated Parkinson’s disease -BOSTON and ATLANTA, Feb. 07, 2024 Inhibikase Therapeutics, Inc. , a.

United statesMiltonh wernerMilton wernerAlex loboInhibikase therapeutics incExchange commissionStern investor relations incCompany contactDivision of hematologic malignanciesInhibikase or companyDrug administrationAbelson tyrosine kinasesChief executive officerHematologic malignanciesReview teamUntreated parkinson

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

United statesAlex loboMiltonh wernerMilton wernerInhibikase or companyCompany contactInhibikase therapeutics incStern investor relations incExchange commissionAbelson tyrosine kinasesOlder adultsChief executive officerAbelson tyrosine kinaseAbleson tyrosineMultiple system atrophyPrivate securities litigation reform act

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib

Inhibikase Therapeutics Announces Publication Highlighting Results from its Phase 1 Studies with Risvodetinib
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

United statesAlex loboMiltonh wernerMilton wernerCompany contactInhibikase or companyExchange commissionStern investor relations incInhibikase therapeutics incInhibikase therapeuticsAbelson tyrosine kinasesOlder adultsChief executive officerAbelson tyrosine kinaseAbleson tyrosineMultiple system atrophy